Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
复制标题
DOI:
10.1084/jem.175.1.169
复制
发表时间:
1992-01-01
期刊:
影响因子:
--
通讯作者:
Reed SG
中科院分区:
文献类型:
--
作者:
Silva JS;Morrissey PJ;Grabstein KH;Mohler KM;Anderson D;Reed SG
Studies were undertaken to determine whether interleukin 10, (IL-10) a cytokine shown to inhibit interferon gamma (IFN-gamma) production, was involved in Trypanosoma cruzi infections in mice. Exogenous IFN-gamma protects mice from fatal infection with T. cruzi. Furthermore, resistant B6D2 mice developed fatal T. cruzi infections when treated with neutralizing anti-IFN-gamma monoclonal antibody (mAb). Thus, endogenous as well as exogenous IFN-gamma is important in mediating resistance to this parasite. Because both T. cruzi-susceptible (B6) and -resistant (B6D2) mouse strains produced IFN-gamma during acute infection, we looked for the concomitant production of mediators that could interfere with IFN-gamma-mediated resistance to T. cruzi. We found that IL-10-specific mRNA was produced in the spleens of mice with acute T. cruzi infections. In addition, spleen cell culture supernatants from infected B6 mice, and to a lesser extent B6D2 mice, elaborated an inhibitor(s) of IFN-gamma production. This inhibitor(s) was neutralized by anti-IL-10 mAb. These experiments demonstrated the production of biologically active IL-10 during T. cruzi infection. In further studies in vitro, it was shown that IL-10 blocked the ability of IFN-gamma to inhibit the intracellular replication of T. cruzi in mouse peritoneal macrophages. Thus, in addition to its known ability to inhibit the production of IFN-gamma, IL-10 (cytokine synthesis inhibitory factor), may also inhibit the effects of IFN-gamma. These experiments demonstrate that IL-10 is produced during infection with a protozoan parasite and suggest a regulatory role for this cytokine in the mediation of susceptibility to acute disease.
登录
查看更多内容
DOI:
10.1084/jem.169.1.59
发表时间:
1989-01-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Heinzel FP;Sadick MD;Holaday BJ;Coffman RL;Locksley RM
通讯作者:
Locksley RM
影响因子:
3.7
作者:
ROTTENBERG, M;LINDQVIST, C;ORN, A
通讯作者:
ORN, A
DOI:
10.1084/jem.170.6.2081
发表时间:
1989-12-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Fiorentino DF;Bond MW;Mosmann TR
通讯作者:
Mosmann TR
影响因子:
56.9
作者:
MOORE, KW;VIEIRA, P;MOSMANN, TR
通讯作者:
MOSMANN, TR
DOI:
10.1084/jem.166.5.1229
发表时间:
1987-11-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Cherwinski HM;Schumacher JH;Brown KD;Mosmann TR
通讯作者:
Mosmann TR